Antibacterial agent 190
Antibacterial agent 190 (compound 16) is a antibacterial agent. Antibacterial agent 190 shows antibacterial activity. Antibacterial agent 190 reduces the bacterial burden of the peritoneum and blood.
For research use only. We do not sell to patients.
- Formula: C39H50N10O4
- Molecular Weight:722.88
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Antibacterial agent 190 shows antibacterial activity with MIC values of 0.12-0.25, 0.03, 0.12, 0.03, 0.12 µg/mL for Staphylococcus aureus USA30, Streptococcus pneumoniae, Enterococcus faecium, Vancomycin-resistant Enterococcus faecium, Linezolid-resistant Enterococcus faecium, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:20 g, 21 NMRI female mice (S. aureus ATCC 25923; i.p.)[1]
-
Dosage:80 mg/kg
-
Administration:S.c.
-
Result:Reduced the bacterial burden of the peritoneum and blood.
Chemical Information
-
Molecular Weight 722.88
-
Formula C39H50N10O4
-
SMILES
C[C@@H]1CC[C@]2([C@H]3C)[C@](C(CC2)=O)([H])[C@@]1([C@H](OC(CN4N=NC(C5=CC=C(N=C5)CN6C=NC7=C6N=CN=C7N8CCNCC8)=C4)=O)C[C@](C)([C@H]3O)C=C)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)